Citation Impact
Citing Papers
Feedback Mechanisms Promote Cooperativity for Small Molecule Inhibitors of Epidermal and Insulin-Like Growth Factor Receptors
2008
Invasion of Human Breast Cancer Cells In vivo Requires Both Paracrine and Autocrine Loops Involving the Colony-Stimulating Factor-1 Receptor
2009
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
2006 Standout
Suppression of Aging in Mice by the Hormone Klotho
2005 StandoutScience
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas
2007 Standout
Differential Roles of Macrophages in Diverse Phases of Skin Repair
2010 Standout
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Group A Streptococcus Activates Type I Interferon Production and MyD88-dependent Signaling without Involvement of TLR2, TLR4, and TLR9
2008 StandoutNobel
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Wound healing and inflammation genes revealed by array analysis of 'macrophageless' PU.1 null mice
2004
EGFR Antagonists in Cancer Treatment
2008 Standout
Elevated CSF1 serum concentration predicts poor overall survival in women with early breast cancer
2013
The insulin-like growth factor system and cancer
2003
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
The insulin-like growth factor system in advanced breast cancer
2003
Cell cycle checkpoint signaling through the ATM and ATR kinases
2001 Standout
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Wound repair and regeneration
2008 StandoutNature
Cushing's syndrome
2015 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Signaling by the cytokine receptor superfamily: JAKs and STATs
1994 Standout
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Modelling glandular epithelial cancers in three-dimensional cultures
2005
Complex networks orchestrate epithelial–mesenchymal transitions
2006 Standout
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2006 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx
1990
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib
2006
Membrane Macrophage Colony-Stimulating Factor on MADB106 Breast Cancer Cells Does Not Activate Cytotoxic Macrophages but Immunizes Rats against Breast Cancer
2001
Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development
2002
Neutrophils and immunity: challenges and opportunities
2006 Standout
The insulin and insulin-like growth factor receptor family in neoplasia: an update
2012
Neutrophils escort circulating tumour cells to enable cell cycle progression
2019 Nature
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
2003 StandoutNobel
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Targeting macrophages: therapeutic approaches in cancer
2018
A tense situation: forcing tumour progression
2009 Standout
Modulation of response to radiation of human lung cancer cells following insulin-like growth factor 1 receptor inactivation
2004
Cancer as an overhealing wound: an old hypothesis revisited
2008 Standout
Ductal Carcinoma In Situ, Complexities and Challenges
2004
Induction of cytokine receptors by glucocorticoids: functional and pathological significance
1998
CSF-1 and Its Receptor in Ovarian, Endometrial and Breast Cancer
1995
Remodelling the extracellular matrix in development and disease
2014 Standout
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
2008 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Capturing complex 3D tissue physiology in vitro
2006 Standout
Recent advances in bone tissue engineering scaffolds
2012 Standout
Eicosanoids and cancer
2010 Standout
SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model
2003
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients
2008
Wound Healing in the PU.1 Null Mouse—Tissue Repair Is Not Dependent on Inflammatory Cells
2003
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Protective and pathogenic functions of macrophage subsets
2011 Standout
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
2000
Macrophage diversity in renal injury and repair
2008
CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract
1997
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
The IGF system and breast cancer.
2001
Resistance to epidermal growth factor receptor-targeted therapy
2005
Novel protein kinases expressed in human breast cancer
1993
Ras activation in human breast cancer
2000
Macrophages Kill T9 Glioma Tumor Cells Bearing the Membrane Isoform of Macrophage Colony Stimulating Factor Through a Phagocytosis-Dependent Pathway
1998
Wound repair and regeneration: Mechanisms, signaling, and translation
2014 Standout
Specific interaction between the bovine papillomavirus E5 transforming protein and the beta receptor for platelet-derived growth factor in stably transformed and acutely transfected cells
1994
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
Involvement of Insulin Receptor Substrate 2 in Mammary Tumor Metastasis
2004
Advances in skin grafting and treatment of cutaneous wounds
2014 StandoutScience
Postnatal mammary gland development requires macrophages and eosinophils
2000
Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients.
1988
A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
2003
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Distinct Role of Macrophages in Different Tumor Microenvironments
2006 Standout
Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.
2002
Click-Chemistry Based High Throughput Screening Platform for Modulators of Ras Palmitoylation
2017 StandoutNobel
Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.
1993
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
2009
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Mandatory second opinion surgical pathology at a large referral hospital
1999
The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance
2008
Expression of insulin-like growth factor-1 receptor in synovial sarcoma: association with an aggressive phenotype.
1999
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
1 The synthesis of ACTH and related peptides by tumours
1990
The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.
1995
ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response
2001
The Role of CSF‐1 in Normal and Neoplastic Breast Physiology
1999
Works of D Carter being referenced
Breast Carcinoma In Situ: Risk Factors and Screening Patterns
2001
Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation.
1997
FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro.
1991
Intralaryngeal barriers to the spread of cancer.
1987
Histologic classification and differential diagnosis of mesothelioma.
1981
Pathology of carcinoma of the lung. Changing patterns.
1982